National Institutes of Health
The National Institutes of Health (NIH) is a leading biomedical research facility in the United States, operating under the Department of Health and Human Services. Established in 1887 and based in Bethesda, Maryland, NIH is the primary agency responsible for biomedical and health-related research in the country. It comprises 27 separate institutes and centers, each focusing on different disciplines within biomedical science. NIH conducts its own scientific research through the Intramural Research Program and provides significant funding for research at external institutions via the Extramural Research Program. With a workforce that includes 1,200 principal investigators and over 4,000 postdoctoral fellows, NIH has been instrumental in major medical breakthroughs, such as the development of vaccines for hepatitis and human papillomavirus, as well as the discovery of treatments for various health conditions. As the world's largest source of medical research funding, NIH continues to advance scientific knowledge and contribute to public health improvements.
Past deals in Personal Health
UCLA Health System
Grant in 2025
Comprised of Ronald Reagan UCLA Medical Center, UCLA Medical Center, Santa Monica; Resnick Neuropsychiatric Hospital at UCLA, Mattel Children's Hospital UCLA, and the UCLA Medical Group with its wide-reaching system of primary-care and specialty-care offices throughout the region, UCLA Health System is among the most comprehensive and advanced healthcare systems in the world.
Caretaker Medical
Grant in 2024
Caretaker Medical, LLC is a developer and manufacturer of wireless patient monitoring devices, based in Charlottesville, Virginia, with additional locations in Surrey, United Kingdom, and Beijing, China. The company offers an innovative wearable monitoring system that utilizes a simple finger cuff to continuously measure vital signs such as blood pressure, heart rate, respiration rate, and other hemodynamic parameters. This device allows clinicians to securely transmit data over cellular networks or Bluetooth, enabling real-time monitoring and improving patient outcomes across the continuum of care—within hospitals, during transport, and after discharge. The system is designed to enhance mobility, simplicity, and cost-effectiveness while ensuring compliance with health regulations. By providing accurate, ICU-level monitoring in a non-invasive format, Caretaker Medical aims to improve patient comfort and facilitate better healthcare delivery.
Teal Health
Grant in 2024
Teal Health is dedicated to improving women's health by providing innovative solutions, starting with at-home cervical cancer screenings. The company has developed the first FDA-approved device that allows women to perform cervical cancer screenings in the comfort and privacy of their own homes. By simplifying the screening process, Teal Health aims to encourage timely screenings and promote early treatment, ultimately working towards the eradication of cervical cancer in the United States. The company's mission focuses on designing health solutions that cater to women's preferences and experiences, addressing the pressing issues in women's health with a commitment to empowerment and accessibility.
Amissa Health
Grant in 2024
Amissa develops mobile and wearable application solutions aimed at alleviating the challenges of Alzheimer's care. The company’s technology empowers caregivers by allowing them to geo-fence and locate loved ones who may wander, remotely monitor their activity and health, and predict behaviors associated with Alzheimer's. In addition to these features, Amissa offers wearable biosensors integrated with a cloud-based data platform that collects biometric data on activity levels, sleep patterns, and physiological changes. This comprehensive approach not only aids caregivers in monitoring patients but also provides valuable insights for researchers seeking to understand disease progression, ultimately enhancing the quality of life for individuals with dementia and related disorders.
Lasarrus
Grant in 2024
Lasarrus is a medical device company founded in 2013 and headquartered in Baltimore, Maryland. The company specializes in developing wearable devices aimed at enhancing the physical therapy experience for patients, particularly those with chronic obstructive pulmonary disease. Lasarrus's innovative device facilitates remote monitoring and telemedicine by capturing physiological and range-of-motion data from various points on the body. This technology provides patients with an affordable, comfortable, and non-invasive means to track their health routines and accelerate their recovery process.
Preeclampsia Foundation
Grant in 2024
Preeclampsia Foundation is a nonprofit that focuses on reducing maternal and infant illness and death due to preeclampsia.
Phenomix Sciences
Grant in 2024
Phenomix Sciences is a biotechnology company founded in 2017 and headquartered in New York, United States. It specializes in the fields of metabolomics and genomics, focusing on developing healthcare solutions for personalized management of chronic diseases. The company has created a data analysis platform aimed at precision medicinal research for obesity management, which features a novel blood test and an AI-driven algorithm. This platform classifies the unique pathophysiological phenotype of patients with obesity, providing healthcare centers with tools and services that enhance the efficacy of obesity management while also reducing side effects and overall costs.
Behaivior
Grant in 2024
Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior integrates wearable devices with machine learning algorithms to analyze real-time data from various physiological metrics, such as heart rate and skin temperature. The company’s platform, known as Recovery, employs this data to deliver timely interventions tailored to the needs of individuals in recovery. By utilizing a SaaS business model, Behaivior aims to democratize mental health recovery and support, assisting users in maintaining their wellness while enabling care providers to enhance their service delivery. Through its proactive approach, Behaivior seeks to improve mental health outcomes and reduce crisis events associated with addiction.
BetterAge
Grant in 2024
BetterAge is a company dedicated to enhancing the health and well-being of older adults through innovative technology solutions. Founded on the principle that all adults can age well regardless of their current circumstances, BetterAge has developed a digital platform designed exclusively for this demographic. The platform provides personalized, objective content tailored to the needs of older adults, offering education and information about disease risks and actionable insights to support informed decision-making. By fostering a network of experts in aging services, health, and technology, BetterAge aims to create thriving communities where older adults can lead active and healthy lives.
Soterya
Seed Round in 2023
On average, we spend a third of our lives in bed. Our self-positioning bed; the Korus™, combined with our AI-driven software, is designed to provide precise sleep therapies improving lifestyle and medical care that benefits sleep wellness and faster recovery at home.
Satio
Grant in 2023
Satio brings a dried blood spot and whole blood collection to the consumer; simple, painless, and clean using patches.
PediaMetrix
Grant in 2023
PediaMetrix Inc. is a healthcare technology company based in Rockville, Maryland, founded in 2018 by a team of entrepreneurs and scientists from Johns Hopkins, NIH, and Oxford. The company specializes in developing a digital tool aimed at improving pediatric head measurement and monitoring. Its primary product, SoftSpot, is a mobile application that utilizes artificial intelligence and computer vision to provide accurate measurements of infants' head shapes and monitor their growth patterns. The app offers parents instant quantitative analysis and personalized repositioning instructions to address flat head syndrome while enabling pediatricians to access comprehensive data for effective clinical decision-making. PediaMetrix's mission is to enhance healthcare outcomes for children by facilitating early detection and management of cranial abnormalities, ultimately aiming to reduce healthcare costs and improve overall pediatric care.
DiagMetrics
Grant in 2023
DiagMetrics is a company that specializes in mask-based diagnostic systems designed to detect respiratory diseases, including Covid-19. Their innovative technology allows for the retrofitting of existing masks to convert breath vapor into a fluid biosample, facilitating non-invasive testing. The system is equipped with Bluetooth capabilities, enabling users to receive test results directly on their smartphones. By providing accessible and efficient diagnostic solutions, DiagMetrics aims to democratize testing and enhance the early detection of respiratory illnesses.
Advent Therapeutics
Grant in 2023
Advent Therapeutics, based in Lumberville, Pennsylvania, is dedicated to developing therapies for micro-orphan applications, specifically targeting serious unmet medical needs in neonatal and pediatric populations. The company focuses on legacy drugs designed to address disorders in newborns, particularly those requiring intensive care in hospital settings. By providing specialized prenatal, neonatal, and pediatric medications, Advent Therapeutics aims to enhance the care pediatricians and healthcare professionals can offer to fragile patients, thereby improving health outcomes for these vulnerable groups.
Domus Diagnostics
Grant in 2023
Domus Diagnostics is a healthcare company based in Park City, Utah, founded in 2021. It specializes in providing a care diagnostics platform focused on respiratory disease home testing services. The company's devices are designed for everyday infectious disease testing and support governments and institutions in conducting large-scale testing during new infectious disease outbreaks. This approach aims to facilitate early treatment and prevent the spread of diseases, potentially mitigating pandemic-scale impacts.
Behaivior
Grant in 2023
Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior integrates wearable devices with machine learning algorithms to analyze real-time data from various physiological metrics, such as heart rate and skin temperature. The company’s platform, known as Recovery, employs this data to deliver timely interventions tailored to the needs of individuals in recovery. By utilizing a SaaS business model, Behaivior aims to democratize mental health recovery and support, assisting users in maintaining their wellness while enabling care providers to enhance their service delivery. Through its proactive approach, Behaivior seeks to improve mental health outcomes and reduce crisis events associated with addiction.
Ria Health
Grant in 2022
Ria Health is an online platform that provides telehealth services aimed at helping individuals modify their relationship with alcohol. It offers personalized treatment plans that include medication-assisted options and behavioral therapies, all facilitated by licensed healthcare professionals. The platform emphasizes continuous monitoring to help users track their progress and maintain accountability. Ria Health also features a mobile app that provides access to educational materials, support groups, and communication with care teams. This comprehensive approach is designed to assist users in managing alcohol consumption and fostering healthier habits, ultimately addressing the challenges associated with alcohol use disorder.
BIOS
Grant in 2022
BIOS Health is a pioneering company focused on developing neural digital therapies by harnessing data-driven insights from the human nervous system. Co-founded by researchers from Cambridge University, the firm aims to revolutionize precision medicine through the identification of neural biomarkers that link nerve activity to various medical conditions. BIOS's innovative approach holds promise for treating chronic diseases such as hypertension, diabetes, rheumatoid arthritis, and neurodegenerative disorders like Parkinson's and Alzheimer's. The company's expertise encompasses a diverse range of fields, including neuroscience, machine learning, software engineering, and biotechnology, allowing it to create advanced solutions for improving the quality of life for individuals suffering from these conditions. Additionally, BIOS is engaged in developing prosthetic connectors that standardize the interface between bionic devices and the body's nervous and soft-tissue systems, enabling enhanced control and feedback for patients with prosthetics.
OvaryIT
Grant in 2022
OvaryIT is a telehealth service dedicated to providing women with accessible and safe contraceptive options. Utilizing advanced science and technology, the company enables its physicians to collaborate with users in developing personalized plans that address both hormonal and non-hormonal contraceptive needs. OvaryIT's proprietary platform enhances patient safety and aids healthcare providers in identifying suitable contraceptive matches, ultimately promoting adherence and enhancing the effectiveness of contraception for patients.
Whitman-Walker Health
Grant in 2022
Whitman-Walker Health provides health and wellness services. They provide HIV, prep, pep, medical and community care, insurance navigation services, gender affirming care and services, youth and family support, legal services, dental health, and behavorial health services.
Coprata
Grant in 2022
Coprata is a digital health and technology platform that offers innovative solutions for gut health monitoring through hands-free stool sampling and automated bowel movement analysis. By utilizing artificial intelligence and normal toilet usage, the company enables individuals to track their gut health and understand the impact of lifestyle choices, providing early warnings of potential health changes. Coprata's technology focuses on detecting and managing both acute and chronic gastrointestinal diseases while also offering insights into infectious diseases. With an emphasis on non-invasive methods, the platform allows for discreet health monitoring without significantly altering daily routines. The company aims to enhance personalized wellness and explores future applications in preventative health and remote patient monitoring.
PediaMetrix
Grant in 2022
PediaMetrix Inc. is a healthcare technology company based in Rockville, Maryland, founded in 2018 by a team of entrepreneurs and scientists from Johns Hopkins, NIH, and Oxford. The company specializes in developing a digital tool aimed at improving pediatric head measurement and monitoring. Its primary product, SoftSpot, is a mobile application that utilizes artificial intelligence and computer vision to provide accurate measurements of infants' head shapes and monitor their growth patterns. The app offers parents instant quantitative analysis and personalized repositioning instructions to address flat head syndrome while enabling pediatricians to access comprehensive data for effective clinical decision-making. PediaMetrix's mission is to enhance healthcare outcomes for children by facilitating early detection and management of cranial abnormalities, ultimately aiming to reduce healthcare costs and improve overall pediatric care.
Enspectra Health
Grant in 2022
Enspectra Health, based in Mountain View, California, develops advanced imaging systems for medical research and diagnosis. Founded in 2012, the company has pioneered the world's first handheld multiphoton imager for human use, capable of visualizing beneath the skin in real-time. Its innovative system combines reflectance confocal and multiphoton laser scanning microscopy to generate multispectral images, enhancing dermatologists' ability to diagnose and treat skin conditions, particularly cancers. Enspectra Health delivers these imaging systems to researchers studying various tissues and has a track record of delivering such systems since its inception.
Epicore Biosystems
Series A in 2022
Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.
Bleep
Grant in 2021
Bleep provides best new CPAP solution on the market. Not sleeping sucks. Not sleeping and spending a fortune on CPAP devices that leak, fall off or leave marks on your face sucks even worse. That’s why they invented the DreamPort Sleep Solution – the world’s first-ever mask less CPAP device. The result is the smallest, lightest, most ergonomically accommodating CPAP solution on the market – a device that fits comfortably and doesn’t restrict your movement – enabling patients to get a better night’s sleep. Their goal is simple – to make the best bleeping CPAP products on the planet. They won’t stop until every sleep apnea patient is sleeping like a baby.
Viora Health
Pre Seed Round in 2021
Viora Health is a health and wellness company focused on advancing health equity among diverse populations. It develops tech-enabled, human-centered programs that utilize social and behavioral engagement to enhance the capacity, satisfaction, outcomes, and revenue for healthcare providers. Viora Health's offerings are designed to improve adherence to diabetes prevention and support patients through online tools that track data and report progress to diabetes prevention programs, facilitating compliance with insurance requirements. Funded by reputable organizations such as the American Heart Association, the National Institutes of Health, Johnson and Johnson, and the National Science Foundation, Viora Health's initiatives have shown significant success, achieving a 75% satisfaction score and double retention rates, while also leading to improved patient outcomes such as reduced stress, increased social support, and better access to food.
Chosen Diagnostics
Grant in 2021
Chosen Diagnostics is a developer of innovative biomarker diagnostic kits designed to enhance healthcare delivery for neonates. The company's primary focus is on diagnosing a prevalent and life-threatening bowel disease in preterm infants. Its diagnostic kit provides more accurate results compared to existing options, facilitating earlier medical intervention. By enabling healthcare professionals to detect critical conditions sooner, Chosen Diagnostics aims to improve treatment outcomes for thousands of low birth weight preterm infants, ultimately contributing to better health and survival rates in this vulnerable population.
Soterya
Seed Round in 2021
On average, we spend a third of our lives in bed. Our self-positioning bed; the Korus™, combined with our AI-driven software, is designed to provide precise sleep therapies improving lifestyle and medical care that benefits sleep wellness and faster recovery at home.
Enspectra Health
Grant in 2021
Enspectra Health, based in Mountain View, California, develops advanced imaging systems for medical research and diagnosis. Founded in 2012, the company has pioneered the world's first handheld multiphoton imager for human use, capable of visualizing beneath the skin in real-time. Its innovative system combines reflectance confocal and multiphoton laser scanning microscopy to generate multispectral images, enhancing dermatologists' ability to diagnose and treat skin conditions, particularly cancers. Enspectra Health delivers these imaging systems to researchers studying various tissues and has a track record of delivering such systems since its inception.
Xtrava Health
Grant in 2021
Xtrava Health, established in 2014 and headquartered in Santa Clara, California, specializes in developing contactless bio-sensing technology for health and wellness applications. The company's flagship product, Butterfly, is a wearable child wellness monitor that automatically tracks vital signs, sleep patterns, feeding, diaper changes, and activities, providing parents with comprehensive insights. Xtrava Health also develops and commercializes simple, accurate, and affordable diagnostic products for both professional and at-home use, focusing on respiratory health, employee wellness, and baby monitoring.
Arcascope
Grant in 2020
Arcascope is a technology company that specializes in developing health and fitness applications. Their primary focus is on creating apps that utilize algorithms to track users' circadian rhythms. By analyzing data from phones and wearable devices, Arcascope accurately monitors the body's internal clock. This information is used to generate personalized recommendations aimed at helping individuals manage their fatigue and improve their overall well-being by aligning with their natural sleep-wake cycles.
Lactiga
Grant in 2020
Lactiga is a biotherapeutics company focused on developing innovative biologics aimed at treating and preventing infections, particularly for patients with Primary Immunodeficiency Diseases. By harnessing the therapeutic potential of human milk, Lactiga seeks to combat severe pathogens and improve the quality of life for individuals with rare immunodeficiencies, such as selective IgA deficiency and common variable immunodeficiency. The company's biotherapeutics are designed to prevent mucosal infections, enabling immunodeficient and immunocompromised individuals to lead healthier lives without the need for invasive treatments.
Samay
Grant in 2020
Samay is a developer of an innovative AI-enabled wearable device focused on remote respiratory health management. The company addresses the growing need for effective chronic obstructive pulmonary disease (COPD) diagnostics and management, projected to incur significant healthcare costs in the coming years. Their patented chest patches provide passive monitoring of lung function, achieving 90% accuracy in COPD diagnosis and 83% accuracy in detecting exacerbation biomarkers. The device continuously tracks vital respiratory metrics, including pulmonary volumes, heart rates, and breathing sounds for two weeks, offering users valuable insights to optimize their respiratory health. Additionally, Samay is creating an AI-assisted management platform that supports patients and healthcare providers throughout the care continuum, enhancing personalized care from the comfort of home.
Intake Health
Grant in 2019
Intake Health is a company focused on continuous passive health monitoring through innovative technology. Its primary product is a device that hangs on a toilet, automatically testing urine from flush water to provide lab-quality results for various health and diet indicators. This device does not require any behavior changes from users, making it easy to integrate into daily life. By utilizing advanced biosensors and wireless technology, the device quantifies specific urinary biomarkers to accurately track hydration and nutrition, delivering instant insights directly to users' smartphones. The company believes that leveraging artificial intelligence alongside thousands of personalized biomarkers collected over time will enhance the prediction of health conditions and support personalized preventive care as its user base expands. Intake Health has received funding from notable organizations such as the National Science Foundation and the National Institutes of Health.
Recovery Force
Grant in 2019
Recovery Force, founded in 2013 and headquartered in Fishers, Indiana, is a company specializing in the development and manufacture of wearable medical technology designed to enhance mobility and circulation. The company's flagship product, MORPH, utilizes S.M.A.R.T. technology incorporating nitinol with a proprietary algorithm to deliver rhythmic, sequential compression that increases blood flow to targeted muscles and tissues. This innovative approach aims to reduce post-operative pain, swelling, and wound healing time, treat chronic conditions like lymphedema, prevent blood clots, and alleviate joint pain and sore muscles. Recovery Force's solutions are designed for use by healthcare professionals, patients, and athletes, addressing the evolving needs of healthcare from hospital to home.
Bruin Biometrics
Grant in 2018
Bruin Biometrics LLC is a medical device company focused on developing and manufacturing biometric sensor-based solutions for the early identification and monitoring of chronic and preventable conditions. Established in 2009 and headquartered in Los Angeles, California, with an additional office in Manchester, United Kingdom, the company exclusively licenses wireless health technologies from the UCLA Wireless Health Institute. Its primary product, the Provizio SEM Scanner, is a handheld wireless device designed for assessing the risk of pressure injuries and ulcers. Additionally, Bruin Biometrics offers the OrthoSonos, an acoustic emission-based monitor for evaluating joint health in both natural and artificial joints. The company aims to provide effective wound care and orthopedic solutions while delivering real-time data capture, analytics, and reporting to enhance healthcare outcomes.
Arcascope
Grant in 2018
Arcascope is a technology company that specializes in developing health and fitness applications. Their primary focus is on creating apps that utilize algorithms to track users' circadian rhythms. By analyzing data from phones and wearable devices, Arcascope accurately monitors the body's internal clock. This information is used to generate personalized recommendations aimed at helping individuals manage their fatigue and improve their overall well-being by aligning with their natural sleep-wake cycles.
Behaivior
Grant in 2018
Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior integrates wearable devices with machine learning algorithms to analyze real-time data from various physiological metrics, such as heart rate and skin temperature. The company’s platform, known as Recovery, employs this data to deliver timely interventions tailored to the needs of individuals in recovery. By utilizing a SaaS business model, Behaivior aims to democratize mental health recovery and support, assisting users in maintaining their wellness while enabling care providers to enhance their service delivery. Through its proactive approach, Behaivior seeks to improve mental health outcomes and reduce crisis events associated with addiction.
HealthRhythms
Grant in 2017
HealthRhythms is a company that specializes in mental health assessment and treatment through an innovative platform that leverages deep machine learning and predictive analytics. Its solution focuses on real-time, objective monitoring of mental health conditions, providing continuous assessments and personalized digital interventions. By accurately measuring mental health status and anticipating clinical deterioration, HealthRhythms enables healthcare providers to identify and manage patients effectively. The platform enhances the care delivery experience for patients, health plans, payers, and research organizations by offering just-in-time interventions tailored to individual patient profiles. This groundbreaking approach aims to improve overall mental health outcomes and facilitate better management of behavioral health.
BioSensics
Grant in 2017
Wearable sensors are transforming healthcare by empowering health researchers, care providers, and patients with new insights.Together with their clinical research and enterprise partners, They develop innovative, market driven, wearable sensor solutions that address some of healthcare’s biggest challenges.
Accure Health
Grant in 2017
Accure Health is a privately held precision medicine company dedicated to developing AI-powered solutions that utilize patients' biomarker profiles. The company focuses on creating innovative technologies that enhance the delivery of precision therapies, ensuring that treatments are tailored to the specific needs of individual patients. Accure's patented technologies integrate advanced protein design, an automated biomarker device, and a scalable food-based production system. This unique combination aims to improve the targeted delivery of RNA and protein therapeutics, facilitating more effective treatment outcomes. With a commitment to "Cure through Accuracy," Accure Health strives to make precision medicine accessible and effective for a diverse patient population.
Health Behavior Solutions
Grant in 2017
Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments. Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching. We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.
Health Behavior Solutions
Grant in 2017
Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments. Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching. We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.
Ossium Health
Grant in 2016
Ossium Health, Inc. is a biotechnology company that specializes in developing and manufacturing advanced cell therapy products aimed at treating blood cancers, improving organ transplantation, and repairing tissue damage caused by radiation exposure. Established in 2016 and based in San Francisco, the company has created a range of therapies, including HPC, Marrow, which consists of human leukocyte antigen (HLA)-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients. Additionally, Ossium offers Chimera, designed to enhance organ transplantation, and Chymalis, which utilizes mesenchymal stem cells from bone marrow to facilitate the healing of damaged bone and muscle tissue. The company also supplies bone marrow cells for research in oncology, immunology, and related fields, focusing on improving health and longevity through innovative bioengineering techniques.
23andMe
Grant in 2016
23andMe, Inc. is a consumer genetics and research company headquartered in Sunnyvale, California, founded in 2006. It specializes in providing direct-to-consumer personal genome services through home-based saliva collection kits. The company offers a range of services, including Health + Ancestry, which provides insights into ancestry, traits, and health, and Ancestry + Traits, which details ancestry breakdown and various trait reports. 23andMe aims to help individuals understand their genetic makeup, enabling users to explore their ancestry, genealogy, and inherited traits. Additionally, the company markets its services to researchers and scientists, offering categorized and searchable genetic data. With a focus on consumer and research services, 23andMe is positioned within the rapidly growing biotech and healthcare sectors, contributing to the understanding of genetics and its implications for health.
Inova Translational Medicine Institute
Grant in 2016
Inova Translational Medicine Institute (ITMI) is a not-for-profit research institute focused on utilizing genomic and clinical data to advance personalized healthcare. As part of the Inova Center for Personalized Health, ITMI fosters collaboration among researchers, clinicians, and consumers to integrate genomic research into patient care, prevention, and wellness strategies. This innovative approach aims to shift healthcare from a reactive model to a predictive one, enhancing longevity and improving health outcomes. ITMI conducts research that generates extensive genomic and clinical datasets, which are valuable for various fields, including computational biology, psychology, and biomedical research. By analyzing genomic information, ITMI seeks to understand disease onset and promote preventative medicine, thereby enhancing treatment efficacy and minimizing adverse reactions.
Health Behavior Solutions
Grant in 2016
Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments. Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching. We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.
Coriell Institute for Medical Research
Grant in 2016
Coriell Institute for Medical Research, founded in 1953 and based in Camden, New Jersey, is an independent non-profit research center dedicated to the study of the human genome. Expert staff and pioneering programs in the fields of personalized medicine, cell biology, cytogenetics, genotyping, and biobanking drive Their mission. The emerging field of personalized medicine draws upon a person’s genomic information to tailor treatments and prescription drug dosing to optimize health outcomes. The Coriell Personalized Medicine Collaborative (CPMC) research study is seeking to understand the usefulness of genetic risk and pharmacogenomics in clinical decision-making and healthcare management.
Health Behavior Solutions
Grant in 2016
Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments. Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching. We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.
Mayo Clinic
Grant in 2016
Mayo Clinic, established in 1863, is a not-for-profit medical group practice based in Rochester, Minnesota. It provides comprehensive medical care, research, and education services across the United States. The clinic offers specialized care in various fields, including diabetes, cancer, neurology, orthopedics, and cardiology. Mayo Clinic Ventures, founded in 1985, is the clinic's corporate venture capital arm, dedicated to swiftly translating innovative healthcare solutions into patient care. It invests in healthcare, life science, big data, and other related sectors to support Mayo's patient care, education, and research efforts.
SpeechVive
Grant in 2016
SpeechVive Inc. is a medical technology company based in Lafayette, Indiana, that focuses on developing innovative communication solutions for individuals with Parkinson's disease. Founded in 2011, the company specializes in the design and manufacture of a wearable speech device aimed at enhancing the speech capabilities of patients. This device effectively reduces background noise, thereby improving the user's ability to hear and facilitating increased speech volume and clarity. By addressing the communication challenges faced by those with Parkinson's disease, SpeechVive aims to help patients lead more normal and fulfilling lives.
Daktari Diagnostics
Grant in 2015
Daktari Diagnostics, Inc. is a healthcare solutions company based in Cambridge, Massachusetts, focused on developing portable point-of-care diagnostic platforms to enhance disease management globally. Founded in 2008, the company offers several innovative products, including Daktari Virology for the detection of Hepatitis C and HIV, Daktari InSight, a cloud-based data management service, and Daktari Sickle Cell, which identifies infants with sickle cell disease from a single drop of blood. Daktari’s technology is designed specifically for resource-poor markets, featuring built-in wireless connectivity that facilitates real-time data sharing among healthcare providers. By delivering critical diagnostic information efficiently, Daktari aims to improve clinical outcomes and support global health initiatives. The company's commitment to affordability and quality ensures that its products are accessible to healthcare professionals and patients worldwide.
Mayo Clinic
Grant in 2014
Mayo Clinic, established in 1863, is a not-for-profit medical group practice based in Rochester, Minnesota. It provides comprehensive medical care, research, and education services across the United States. The clinic offers specialized care in various fields, including diabetes, cancer, neurology, orthopedics, and cardiology. Mayo Clinic Ventures, founded in 1985, is the clinic's corporate venture capital arm, dedicated to swiftly translating innovative healthcare solutions into patient care. It invests in healthcare, life science, big data, and other related sectors to support Mayo's patient care, education, and research efforts.
Insightfil
Grant in 2014
Insightfil is a company focused on enhancing patient outcomes by addressing medication errors and improving adherence rates among patients. With a goal of increasing adherence from the typical 40% to the National Institutes of Health target of 75%, the company has developed an innovative platform that automates the dispensing of medications based on doctor prescriptions. This platform includes a reminder system to support patients in following their medication regimens, thereby assisting healthcare providers in their efforts to optimize care. Additionally, Insightfil offers a unique Personalized Wellness Portfolio, which is designed to connect patients, clinics, and pill manufacturers, streamlining the administration of therapy and reducing waste associated with unused drugs and packaging. Through these initiatives, Insightfil aims to improve the overall efficiency of medication management in healthcare.
23andMe
Grant in 2014
23andMe, Inc. is a consumer genetics and research company headquartered in Sunnyvale, California, founded in 2006. It specializes in providing direct-to-consumer personal genome services through home-based saliva collection kits. The company offers a range of services, including Health + Ancestry, which provides insights into ancestry, traits, and health, and Ancestry + Traits, which details ancestry breakdown and various trait reports. 23andMe aims to help individuals understand their genetic makeup, enabling users to explore their ancestry, genealogy, and inherited traits. Additionally, the company markets its services to researchers and scientists, offering categorized and searchable genetic data. With a focus on consumer and research services, 23andMe is positioned within the rapidly growing biotech and healthcare sectors, contributing to the understanding of genetics and its implications for health.
Daktari Diagnostics
Grant in 2014
Daktari Diagnostics, Inc. is a healthcare solutions company based in Cambridge, Massachusetts, focused on developing portable point-of-care diagnostic platforms to enhance disease management globally. Founded in 2008, the company offers several innovative products, including Daktari Virology for the detection of Hepatitis C and HIV, Daktari InSight, a cloud-based data management service, and Daktari Sickle Cell, which identifies infants with sickle cell disease from a single drop of blood. Daktari’s technology is designed specifically for resource-poor markets, featuring built-in wireless connectivity that facilitates real-time data sharing among healthcare providers. By delivering critical diagnostic information efficiently, Daktari aims to improve clinical outcomes and support global health initiatives. The company's commitment to affordability and quality ensures that its products are accessible to healthcare professionals and patients worldwide.
Xhale
Grant in 2014
Xhale is a company based in Gainesville, Florida, founded in 2005, that specializes in developing advanced patient monitoring technologies. The company is known for its innovative SMART medication adherence monitoring technology and a propofol monitor, both aimed at enhancing patient care in clinical settings. Xhale's devices are designed to improve conventional pulse oximetry by enabling the monitoring of critical patient parameters through a simple, effective single-point-of-contact sensor. In 2010, Xhale successfully commercialized its HyGreen hand hygiene monitoring system, which later became a separate entity with its own management team. The company's focus on expanding the capabilities of patient monitoring is intended to improve health outcomes in hospitals and other clinical environments.
Insightfil
Grant in 2014
Insightfil is a company focused on enhancing patient outcomes by addressing medication errors and improving adherence rates among patients. With a goal of increasing adherence from the typical 40% to the National Institutes of Health target of 75%, the company has developed an innovative platform that automates the dispensing of medications based on doctor prescriptions. This platform includes a reminder system to support patients in following their medication regimens, thereby assisting healthcare providers in their efforts to optimize care. Additionally, Insightfil offers a unique Personalized Wellness Portfolio, which is designed to connect patients, clinics, and pill manufacturers, streamlining the administration of therapy and reducing waste associated with unused drugs and packaging. Through these initiatives, Insightfil aims to improve the overall efficiency of medication management in healthcare.
Noom
Grant in 2013
Noom, Inc. is a New York-based company that specializes in mobile health coaching through a psychology-based digital health platform. Founded in 2008, Noom develops a mobile application that combines evidence-based curricula, personalized coaching, and data-driven insights to help users achieve their health and wellness goals, including weight management and chronic disease prevention. The platform offers scalable tools for exercise and nutrition coaching, utilizing artificial intelligence to facilitate behavioral change. Recognized for its innovative approach, Noom has received multiple grants from the National Institutes of Health and was the first mobile application certified by the Centers for Disease Control as a diabetes prevention program. The company also caters to business enterprises, supporting organizations in promoting employee health. With additional offices in Seoul and Tokyo, Noom continues to expand its global reach and impact on personal health management.
Insightfil
Grant in 2013
Insightfil is a company focused on enhancing patient outcomes by addressing medication errors and improving adherence rates among patients. With a goal of increasing adherence from the typical 40% to the National Institutes of Health target of 75%, the company has developed an innovative platform that automates the dispensing of medications based on doctor prescriptions. This platform includes a reminder system to support patients in following their medication regimens, thereby assisting healthcare providers in their efforts to optimize care. Additionally, Insightfil offers a unique Personalized Wellness Portfolio, which is designed to connect patients, clinics, and pill manufacturers, streamlining the administration of therapy and reducing waste associated with unused drugs and packaging. Through these initiatives, Insightfil aims to improve the overall efficiency of medication management in healthcare.
Insightfil
Grant in 2012
Insightfil is a company focused on enhancing patient outcomes by addressing medication errors and improving adherence rates among patients. With a goal of increasing adherence from the typical 40% to the National Institutes of Health target of 75%, the company has developed an innovative platform that automates the dispensing of medications based on doctor prescriptions. This platform includes a reminder system to support patients in following their medication regimens, thereby assisting healthcare providers in their efforts to optimize care. Additionally, Insightfil offers a unique Personalized Wellness Portfolio, which is designed to connect patients, clinics, and pill manufacturers, streamlining the administration of therapy and reducing waste associated with unused drugs and packaging. Through these initiatives, Insightfil aims to improve the overall efficiency of medication management in healthcare.
Viora Health
Viora Health is a health and wellness company focused on advancing health equity among diverse populations. It develops tech-enabled, human-centered programs that utilize social and behavioral engagement to enhance the capacity, satisfaction, outcomes, and revenue for healthcare providers. Viora Health's offerings are designed to improve adherence to diabetes prevention and support patients through online tools that track data and report progress to diabetes prevention programs, facilitating compliance with insurance requirements. Funded by reputable organizations such as the American Heart Association, the National Institutes of Health, Johnson and Johnson, and the National Science Foundation, Viora Health's initiatives have shown significant success, achieving a 75% satisfaction score and double retention rates, while also leading to improved patient outcomes such as reduced stress, increased social support, and better access to food.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.